Cooper Co.'s (COO) Unit Gets FDA 510(k) Clearance for Avaira Toric Lenses
Tweet Send to a FriendGet Alerts COO Hot Sheet
Price: $120.75 -0.77%
Overall Analyst Rating:
BUY (
Up)
Dividend Yield: 0.1%
Revenue Growth %: +11.4%
Overall Analyst Rating:
BUY (
Up)Dividend Yield: 0.1%
Revenue Growth %: +11.4%
Trade COO Now!
The Cooper Companies, Inc. (NYSE: COO) today announced that the U.S. Food and Drug Administration has granted a Special 510(k) clearance for CooperVision's Avaira Toric two-week silicone hydrogel contact lenses for astigmatism.
CooperVision will re-launch Avaira Toric with shipments available for select distribution beginning in early May 2012.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
CooperVision will re-launch Avaira Toric with shipments available for select distribution beginning in early May 2012.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Actavis (ACT), Kissei Pharma Sue Sandoz, Hetero Over Rapaflo Patent
- Diamondback Energy (FANG) Prices 6M Common Secondary Offering
- Orchard Supply (OSH) Receives Approval of All First Day Motions
Create E-mail Alert Related Categories
Corporate News, FDA
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
